Participants living with Obesity or Overweight with at least 1 comorbidity research hub

A Phase IIb Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD5004 in Participants Living with Obesity or Overweight with Comorbidity

This study is testing a new medicine, AZD5004, for people who are overweight or have obesity and other health issues. It aims to see if the medicine helps with weight loss and if it's safe and well-tolerated over 26 weeks.